TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ZYME

Zymeworks Inc.

Healthcare · Biotechnology

27.50$ +4.7% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Zymeworks Inc. (ZYME): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/05/2026.

Next report 11/05/2026
Last report 08/06/2026
Earnings surprise by quarter (%)
Q3 23 · 12.8 % 23 Q4 23 · 53.5 % 23 Q1 24 · -44.8 % 24 Q2 24 · -58.1 % 24 Q3 24 · 4.9 % 24 Q4 24 · -236.2 % 24 Q1 25 · 57.1 % 25 Q2 25 · 105.8 % 25 Q3 25 · 18.8 % 25 Q4 25 · -70.6 % 25 Q1 26 · -490.0 % 26 Q2 26 · -10.7 % 26

EPS estimate beaten

Full history 19 of 39 quarters (49%)
Last 16 quarters 8 of 16 quarters (50%)

Earnings Call Transcripts

Search all transcripts →

  • 05/07/2026 Earnings Call Q1 2026 Open →
  • 03/02/2026 Earnings Call Q4 2025 Open →
  • 11/07/2025 Earnings Call Q3 2025 Open →
  • 08/08/2025 Earnings Call Q2 2025 Open →
  • 05/08/2025 Earnings Call Q1 2025 Open →
  • 03/05/2025 Earnings Call Q4 2024 Open →
  • 10/31/2024 Earnings Call Q3 2024 Open →
  • 08/01/2024 Earnings Call Q2 2024 Open →
  • 05/02/2024 Earnings Call Q1 2024 Open →

News on This Stock

  • 08/25/2026 Zymeworks Inc. (ZYME): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/06/2026 Zymeworks Inc. (ZYME): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?